The global veterinary artificial insemination market size was valued at USD 4.19 Billion in 2022 and is anticipated to reach USD 7.36 Billion by 2031, expanding at a CAGR of 6.45% during the forecast period, 2023-2031. Artificial insemination is a preferred method, as the semen is easily transported and more females can be impregnated simultaneously; therefore, the demand for artificial insemination is expected to increase in the coming years.
Artificial insemination is the process of collecting sperm cells and implanting it in female’s cervix or uterine cavity. Equipment and reagents are used for artificial insemination. Rising prevalence of diseases has led to the adoption of artificial insemination, as this technique reduces the transmission of diseases. Artificial inseminationis also used for producing progenies with desired traits.
Veterinary Artificial Insemination Market Trends, Drivers, Restraints, and Opportunities
- Reduction of risks associated with artificial insemination propels the adoption of artificial insemination instruments.
- High cost of devices hampers the adoption of veterinary artificial insemination instruments.
- Rise in adoption of new technologies, including artificial intelligence, by several players is driving the demand for veterinary artificial insemination instruments.
Scope of Veterinary Artificial Insemination Market Report
The report on the global veterinary artificial insemination market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.
Attributes
|
Details
|
Report Title
|
Veterinary Artificial Insemination Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
Base Year
|
2022
|
Historic Data
|
2016–2021
|
Forecast Period
|
2023–2031
|
Segmentation
|
Product Types (Artificial Insemination Syringes, Insemination Sheaths, Artificial Insemination Applicators/Straws, Thawers, Embryo Transfer Equipment, Artificial Insemination Kits, Accessories, Reagent Media, and Others), Animal Types (Ruminants, Equine, Canine & Feline, and Others), Techniques (Intrauterine Tub Peritoneal Insemination, Intracervical Insemination, Intrauterine Insemination, and Intratubal Insemination), End-users (Veterinary Hospitals, Veterinary Clinics, and Others)
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
|
Report Coverage
|
Market Scope, Analysis, Share, Competitive Analysis, Growth Facts, Restraints, Opportunities,and Revenue Forecast
|
Key Players Covered in the Report
|
Merck Animal Health, Bovine Elite, Swine Genetics, LLC., PBS Animal Health, Revival Animal Health, ABS Global, Jorgensen Labs, Santa Cruz Biotechnology, Orgensen Labs, IMV Technologies Group, Agtech, Alta Genetics and KRUUSE
|
Veterinary Artificial Insemination Market Segment Insights
Product Types Segment Analysis
Based on product types, the veterinary artificial insemination market can be segmented into artificial insemination syringes, insemination sheaths, artificial insemination applicators/straws, thawers, embryo transfer equipment, artificial insemination kits, and others.
The artificial insemination kits segment is projected to grow at a significant pace during the forecast period owing to its use for embryo transfer and semen cryopreservation.
Animal Types Segment Analysis
In the terms of animal types, the market can be segregated into ruminants, equine, canines & feline, and others. The ruminants segment is projected to grow at a considerable pace during the forecast period due to increase in the adoption of ruminants for artificial insemination procedures, rising milk consumption, and growing demand for beef.
Techniques Segment Analysis
On the basis of techniques, the veterinary artificial insemination market can be fragmented into intrauterine tub peritoneal insemination, intracervical insemination,intrauterine Insemination, and intratubal insemination.The intrauterine tube peritoneal insemination segment holds a considerable share of the market and is projected to expand at a rapid pace during the forecast period.
Advantages of using the intrauterine tub peritoneal insemination include requirement for less sperm cell for the insemination process and the time required is less to infuse semen after placing the catheter into the uterine.
End-User Segment Analysis
In terms of end-users, the market can be classified as veterinary hospitals, veterinary clinics, and others. The veterinary hospitals segment holds a significant share of the market owing to the increase in the number of veterinary hospitals performing artificial insemination procedures and rising number of veterinarians.
Regional Analysis
Based on regions, the global veterinary artificial Insemination market can be categorized as North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America accounts for a considerable share of the global market.
The US is expected to constitute a significant share of the market during the forecast period. Rising disposable income and growing awareness among the consumers regarding pet products are propelling the demand for veterinary artificial insemination procedures.
Segments
Product Types
- Artificial Insemination Syringe
- Insemination Sheath
- Artificial Insemination Applicators/Straws
- Thawer
- Embryo Transfer Equipment
- Artificial Insemination Kits
- Others
Animal Types
- Ruminants
- Equine
- Canine & Feline
- Others
Techniques
- Intrauterine Tub Peritoneal Insemination
- Intracervical Insemination
- Intrauterine Insemination
- Intratubal Insemination
End-users
- Veterinary Hospitals
- Veterinary Clinics
- Others
Regions
- North America
- Europe
- Latin America
- Asia Pacific
- Middle East & Africa
Key Players
- Merck Animal Health
- Bovine Elite
- Swine Genetics, LLC.
- PBS Animal Health
- Revival Animal Health
- ABS Global
- Jorgensen Labs
- Santa Cruz Biotechnology
- Orgensen Labs
- IMV Technologies Group
- Agtech
- Alta Genetics
- KRUUSE
Competitive Landscape
Key players in the global veterinary artificial insemination market include Merck Animal Health, Bovine Elite, Swine Genetics, LLC., PBS Animal Health, Revival Animal Health, ABS Global, Jorgensen Labs, Santa Cruz Biotechnology, Orgensen Labs, IMV Technologies Group, Agtech, Alta Genetics and KRUUSE.
They engage in mergers & acquisitions, collaborations, agreements, and partnerships as growth strategies to strengthen their geographical presence